22-22245287-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007128.4(VPREB1):āc.388G>Cā(p.Glu130Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000715 in 1,399,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007128.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPREB1 | NM_007128.4 | c.388G>C | p.Glu130Gln | missense_variant | 2/2 | ENST00000403807.4 | NP_009059.1 | |
VPREB1 | NM_001303509.2 | c.385G>C | p.Glu129Gln | missense_variant | 2/2 | NP_001290438.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPREB1 | ENST00000403807.4 | c.388G>C | p.Glu130Gln | missense_variant | 2/2 | 1 | NM_007128.4 | ENSP00000385361 | P2 | |
VPREB1 | ENST00000302273.2 | c.385G>C | p.Glu129Gln | missense_variant | 2/2 | 3 | ENSP00000304590 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000577 AC: 1AN: 173334Hom.: 0 AF XY: 0.0000108 AC XY: 1AN XY: 92440
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1399064Hom.: 0 Cov.: 39 AF XY: 0.00000145 AC XY: 1AN XY: 691808
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 12, 2024 | The c.388G>C (p.E130Q) alteration is located in exon 2 (coding exon 2) of the VPREB1 gene. This alteration results from a G to C substitution at nucleotide position 388, causing the glutamic acid (E) at amino acid position 130 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at